Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene 10 (HIGD1AP10) is a human pseudogene; it does not encode a protein and is not considered a canonical drug target. Its name and abbreviation are similar to HIGD1A, a protein-coding gene with well-described roles in mitochondrial homeostasis, cellular stress response, and potential involvement in cancer, inflammation, and neurodegenerative diseases. However, no scientific literature details any function, disease linkage, or drug interaction for HIGD1AP10 itself[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 10 (HIGD1AP10).